Trey Anastasio Band And Vulfpeck Announce Red Rocks Amphitheatre Performance

first_imgLast summer, Vulfpeck had the pleasure of making their debut at the famed Red Rocks Amphitheatre in Morrison, CO. Today, they’ve announced a big return to the venue, this time supporting the Trey Anastasio Band! It’s a double billing guaranteed to make any jam fan’s jaw drop.Trey Anastasio has been very quiet with his solo project in 2016. After releasing Paper Wheels and supporting it with a string of shows at the end of 2015, the band has only performed a twice in 2016. This headlining set at Red Rocks may be the signal of more TAB in 2017, or it could just be a one-off performance at a world-class venue. Either way, we’re certainly excited at the prospect of seeing the Trey Anastasio Band and Vulfpeck on the same night – May 31st, 2017.Vulfpeck has also announced that they will be performing at the Ogden Theatre in Denver, CO, one night prior to this Red Rocks show. Tickets for that show will only be available as bundles with Red Rocks, for now. Tickets will be available through a real time presale beginning Wednesday, November 16th at 10:00am MST and ending Friday, November 18st at 10:00am MST, and can be found here. The general on sale starts this Saturday, November 19th, at 10 AM MST via AXS.last_img read more

Continue reading

Osimhen will give Napoli 200%, says ex-Wolfsburg manager

first_img “He knows how to descend in every reality, he always gives 200 percent,” the German coach added. “He makes a great central striker because he is the classic number 9. “Not only that, but he also played outside for me in 4-2-3-1. He was young and he’s fast, but it is in front of goal that he can make the difference because he has a great flair for the goal.” There have also been questions about how Osimhen can play alongside Napoli’s all-time top scorer Mertens and Labbadia believes both men can fit in together. “They can coexist, they have different and complementary characteristics,” he said. read also:Higuain’s replacement: Cannavaro unsure about Osimhen This same thought was also echoed by Andrea D’Amico, an associate of Osimhen’s current agent, William D’Avila. “It is clear that when you join an important team, there is always competition,” D’Amico told Radio Marte. “Napoli have had many champions who have been able to coexist to create healthy internal competition.” FacebookTwitterWhatsAppEmail分享 Former Wolfsburg manager, Bruno Labbadia, is confident that Napoli new boy, Victor Osimhen, will prove himself come rain, sunshine in the Italian league. According to him, the Nigerian will blend well with the current Partenopei frontman, Dries Mertens in the attack and give the club desired results. The 21-year-old Nigeria international sealed a move to the San Paolo from LOSC Lille last Friday for €50 million, much to the excitement of Napoli fans and supporters in his home country. He is expected to be the main striker for the club, with Poland striker Arkadiusz Milik anticipated to leave the Campania capital. Osimhen comes in having scored 18 goals in 38 competitive outings for Lille. He began his senior career at Wolfsburg under the tutelage of Labbadia, after impressing for Nigeria at the 2015 Under-17 World Cup in Chile where he scored 10 goals in seven matches to finish as top scorer. Things never went well for Osimhen at Wolfsburg, as injuries limited him to just 16 appearances in two years with no goals. He however found revival at Belgian club Charleroi where he netted 20 goals in 36 appearances. “When he has the ball on his feet, he is formidable and in one on one he is very strong,” Labbadia was quoted saying in Il Mattino as reported by TuttoMercato, “and then he is very good in running without the ball to be found free by his companions. Promoted ContentWho Is The Most Powerful Woman On Earth?From Enemies To Friends: 10 TV Characters Who Became Close6 Reasons Sharks Are Afraid Of DolphinsWhat’s Up With All The Female Remakes?7 Truly Incredible Facts About Black HolesFantastic-Looking (and Probably Delicious) Bread ArtBirds Enjoy Living In A Gallery Space Created For Them5 Of The World’s Most Unique Theme ParksYou’ve Only Seen Such Colorful Hairdos In A Handful Of Anime10 Gorgeous Bollywood Divas Who Earn A LotTV Characters Who Hated Each Other But Later Became Friends6 Extreme Facts About Hurricanescenter_img Loading… last_img read more

Continue reading

Ruling set for February

first_imgFreedom Radio challengeFreedom Radio Inc’s constitutional challenge against the Guyana National Broadcasting Authority (GNBA) increasing the annual broadcast fee and imposing Government-mandated broadcasts during prime time hours is set for ruling on February 15, 2018.The matter came up for hearing at the Supreme Court on Wednesday when acting Chief Justice Roxane George, SC, ordered both sides to put their submissions to the court in writing.Attorney for the applicant, Anil Nandlall has until December 15 for his submissions in writing to the court while Attorney General Basil Williams has until February 8 to submit his response to Nandlall’s submissions. The acting Chief Justice indicatedFreedom Radio Inc Director, Irfaan Alithereafter that the matter was fixed for ruling on February 15, 2018.In the constitutional challenge that was filed on behalf of Freedom Radio Director Irfaan Ali, Nandlall and Associates are calling on the court to place on hold the enforcement of several provisions in the Broadcasting Act until the determination of the Judiciary. The sworn affidavit, filed in Ali’s name, claims that provisions in the Broadcast Act expropriate the business’s airwaves causing it to lose on its revenue during ‘prime time’, without compensation.The affidavit states Freedom Radio Inc is in the business of selling airtime for reward and the provisions in question are not only onerous but are in fact unconstitutional since they violate guaranteed and protected rights and freedoms. The coalition Administration earlier this year enacted broadcast legislation which compels local broadcasters to broadcast Government programmes under the ambit of “public service programmes”. Freedom Radio Inc, which is owned and managed by the Opposition People’s Progressive Party (PPP), had highlighted in its legal documents that “between the hours of 06:00h and 22:00h are considered prime-time; this means that these hours attract the highest rates of rewards”.The radio station contends that an hour during this period can easily be sold at a more competitive rate – higher depending upon the particular day of the week – and as such, the requirement by Government in fact “expropriates” money from Freedom Radio without compensation. The Opposition station argues that the move was in fact unconstitutional, since it violated fundamentals rights and freedoms, which enjoy protection under the Constitution of Guyana.The applicant further highlighted that the fees have been increased to $7.5 million annually, up from the $2.5 million of previous payments. Freedom Radio Inc previously paid $2.5 million annually for its Broadcasting Licence in addition to another payment of $633,600 for its Spectrum/Frequency. These fees were paid over to the then National Frequency Management Unit (NFMU), the predecessor to the Guyana Broadcasting Authority which came into being with the assent of Head of State, David Granger to the amended broadcasting legislation.Under the new arrangement, the Administration introduced a zoning system and charges fees for each zone. According to Freedom Radio in its challenge, with the new zoning system, the fee “for broadcasting licence to broadcast in the very areas that it is now transmitting would skyrocket from $2,500,000 annually, to over $7,500,000 annually”.last_img read more

Continue reading

Beckman Coulter offers largest range of single color CEIVD and ASR conjugated

first_imgBeckman Coulter has more than 30 years’ experience in conjugated antibody development and manufacturing which has seen them command a market leading position. The company also builds efficiency into its antibody labeling with the product specificity on the top of the cap label to speed up product identification and workflow. Dr Koksch referred to a recent study published in Nature which showed that monoclonal antibodies were among the most commonly used tools in life sciences but also the greatest source of false findings. Poor quality conjugated antibodies, their specifications and performance can significantly distort data interpretation, in particular when analyzing abnormal populations.He added: Jul 30 2018Beckman Coulter Life Sciences now offers its largest portfolio of single color CE-IVD and ASR (analyte-specific reagent) conjugated antibodies. With the recent launch of two Kappa and two Lambda polyclonal antibodies, the company has introduced more than 30 additional CE-IVD reagents and 10 new ASRs in the last year. The entire portfolio of single color antibodies for flow cytometry is manufactured under Good Manufacturing Practices (GMP). The portfolio is featured at the 70th American Association for Clinical Chemistry (AACC) Annual Scientific Meeting and Clinical Laboratory Expo (CLE), being held July 29 – August 2, 2018 in Chicago. Beckman Coulter Life Sciences, part of the Danaher Corporation, is exhibiting on booth #3612 alongside Beckman Coulter Diagnostics (another Danaher company).Dr Mario Koksch, Vice President and General Manager of Beckman Coulter’s Cytometry Business Unit, said: To be able to routinely run Lab Developed Tests (LDTs), a high-end lab needs skilled staff with significant expertise in data interpretation.  However, even with the right staff and robust procedures, poor reagent quality often leads to failed quality controls, challenges in interpreting data –  and can even lead to false results.The list of potential pitfalls associated with poor antibodies is long and can have a negative impact on a study’s outcome.This is because of lack of reproducibility across lots, poor conjugation quality, low binding affinity, and non-specific staining.” High standard, single color reagents are at the heart of robust and consistent lab-developed tests (LDTs). Even so, establishing robust, accurate and reproducible assays can be a challenge.Several studies show the inadequacy of non-clinical-grade reagents because of inferior performance and problems around reproducibility.” Source:https://www.beckman.comlast_img read more

Continue reading